Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Journal of Data Mining in Genomics & Proteomics
|
March 8, 2016
Towards Better Precision Medicine: PacBio Single-Molecule Long Reads Resolve the Interpretation of HIV Drug Resistant Mutation Profiles at Explicit Quasispecies (Haplotype) Level
Da Wei Huang, Castle Raley, Min Kang Jiang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 6, 2022
Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment
Brian P Epling, Joseph M Rocco, Kristin L Boswell, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 23, 2022
COVID-19 redux: clinical, virologic, and immunologic evaluation of clinical rebound after nirmatrelvir/ritonavir
Brian P Epling, Joseph M Rocco, Kristin L Boswell, et al.
Frontiers in Immunology
|
September 26, 2024
Alterations in the plasma proteome persist ten months after recovery from mild to moderate SARS-CoV-2 infection
Julio A Huapaya, Salina Gairhe, Shreya Kanth, et al.
The Journal of Infectious Diseases
|
February 21, 2023
Vaccination Ameliorates Cellular Inflammatory Responses in SARS-CoV-2 Breakthrough Infections
Julio A Huapaya, Jeanette Higgins, Shreya Kanth, et al.
Plos One
|
June 18, 2025
Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment
Elizabeth S Munroe, Greg A Grandits, Robert C Hyzy, et al.
The Lancet. Microbe
|
May 30, 2024
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study
Tomas O Jensen, Thomas A Murray, Greg A Grandits, et al.
The Journal of Infectious Diseases
|
November 10, 2023
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19
Tomas O Jensen, Greg A Grandits, Mamta K Jain, et al.
Annals of Internal Medicine
|
August 29, 2022
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
, Angela J Rogers, Deborah Wentworth, et al.
Annals of Internal Medicine
|
August 8, 2022
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial
, Christina Barkauskas, Eleftherios Mylonakis, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Journal of Data Mining in Genomics & Proteomics
|
March 8, 2016
Towards Better Precision Medicine: PacBio Single-Molecule Long Reads Resolve the Interpretation of HIV Drug Resistant Mutation Profiles at Explicit Quasispecies (Haplotype) Level
Da Wei Huang, Castle Raley, Min Kang Jiang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 6, 2022
Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment
Brian P Epling, Joseph M Rocco, Kristin L Boswell, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 23, 2022
COVID-19 redux: clinical, virologic, and immunologic evaluation of clinical rebound after nirmatrelvir/ritonavir
Brian P Epling, Joseph M Rocco, Kristin L Boswell, et al.
Frontiers in Immunology
|
September 26, 2024
Alterations in the plasma proteome persist ten months after recovery from mild to moderate SARS-CoV-2 infection
Julio A Huapaya, Salina Gairhe, Shreya Kanth, et al.
The Journal of Infectious Diseases
|
February 21, 2023
Vaccination Ameliorates Cellular Inflammatory Responses in SARS-CoV-2 Breakthrough Infections
Julio A Huapaya, Jeanette Higgins, Shreya Kanth, et al.
Plos One
|
June 18, 2025
Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment
Elizabeth S Munroe, Greg A Grandits, Robert C Hyzy, et al.
The Lancet. Microbe
|
May 30, 2024
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study
Tomas O Jensen, Thomas A Murray, Greg A Grandits, et al.
The Journal of Infectious Diseases
|
November 10, 2023
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19
Tomas O Jensen, Greg A Grandits, Mamta K Jain, et al.
Annals of Internal Medicine
|
August 29, 2022
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
, Angela J Rogers, Deborah Wentworth, et al.
Annals of Internal Medicine
|
August 8, 2022
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial
, Christina Barkauskas, Eleftherios Mylonakis, et al.
Page
of 2